Evidence map›Paper›PMID 42337535›Full record

ArticleBMC psychiatry2026

Multicenter, cluster-based, superiority trial of a multicomponent lifestyle intervention versus usual care for reducing cardiometabolic risk in individuals with psychotic disorders over 36 months: the LAGOM protocol.

Hemen Najar, Erik Jedenius, Andreas Fröberg, Anna Olofsson, Caroline Holmbom, Cathrin Kölborg Björlin, Christina Hagberg, Elin Saari-Bladmyr, Emelie Hantelius, Erik Wålinder and 10 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06781801 (Longitudinal Approach to Generate Positive Cardiometabolic Health Outcomes in Severe Mental Illness), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06781801 narecruitingnot on this map

Longitudinal Approach to Generate Positive Cardiometabolic Health Outcomes in Severe Mental Illness

TypeinterventionalSponsorVastra Gotaland RegionRan2025 to 2029Enrolled650ConditionsPsychotic DisordersArmsIntervention
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hemen NajarDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden. hemen.najar@gu.se.ORCID 0000-0002-7043-1135
Erik JedeniusDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Andreas FröbergDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Anna OlofssonDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Caroline HolmbomDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Cathrin Kölborg BjörlinDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Christina HagbergDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Elin Saari-BladmyrDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Emelie HanteliusDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Erik WålinderDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Eva AndreassonDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Joacim GustafssonDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Lennart LundinSwedish Schizophrenia Association, Gothenburg, Sweden.
Lina KlysingDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Louise RundqvistGothia Forum, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Nadja KörvekDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Pia RydellDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Sandra HederDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Zangin ZeebariJönköping International Business School, Jönköping University, Jönköping, Sweden.
Christopher HolmbergDepartment of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiometabolic conditions-including cardiovascular disease, type 2 diabetes, and obesity-are highly prevalent among individuals with psychotic disorders. These conditions contribute substantially to reduced life expectancy, diminished quality of life, and increased societal and economic burdens. Thus, effective, individualized interventions are urgently needed. Outpatient psychiatric clinics offer an ideal setting for such efforts owing to regular patient contact and access to multidisciplinary care. We have developed a comprehensive, clinically integrated trial aimed at improving cardiometabolic health, promoting healthier lifestyles, and enhancing quality of life for individuals with psychotic disorders receiving care in the Greater Gothenburg region.

methodsLAGOM is a multicenter, naturalistic, quasi-experimental case‒control trial conducted across six geographically separate outpatient psychosis clinics within the Department of Psychotic Disorders at Sahlgrenska University Hospital, a multi-site university hospital in the Greater Gothenburg region. A total of 650 adults with psychotic disorders will be recruited from these clinics. Two clinics will implement the LAGOM intervention, whereas four will serve as control sites delivering usual care. The intervention is embedded within routine psychiatric care and grounded in behavioral science. It includes comprehensive cardiometabolic risk assessments, two visual motivational tools (QRISK3 and a body composition analyzer), personalized follow-up plans, risk-oriented referrals to primary care, and structured education for patients, relatives, and staff. The intervention is designed to be scalable, sustainable, and tailored to individual patient needs. DISCUSSION: If proven superior to usual care, this pragmatic, multicomponent intervention-delivered within routine psychiatric care-could improve cardiometabolic health and quality of life for individuals with psychotic disorders. Embedding the intervention within existing clinical structures enhances its scalability and feasibility and, if effective, could serve as a model for wider implementation.

trial registrationClinicalTrials.gov (NCT06781801; date registered: 16 January 2025). TRIAL STATUS: Recruitment started on 27 February 2025 and will be completed on 31 December 2026. The current clinical investigation plan version is 3.1, dated 21 October 2025.

Indexed as

Cardiovascular DiseasesLife StylePsychotic DisordersRisk Reduction BehaviorAdultCardiometabolic Risk FactorsCase-Control StudiesDiabetes Mellitus, Type 2Equivalence Trials as TopicFemaleHumansMaleMulticenter Studies as TopicNon-Randomized Controlled Trials as TopicObesityQuality of LifeBehavior change interventionCardiometabolic risk factorsCardiovascular disease preventionCost-effectivenessIntegrated health careMetabolic syndromeMulticomponent interventionPragmatic clinical trialPsychotic disordersQuality of life

Identifiers

PMID42337535
PMCPMC13339501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.